The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature
Abstract
POEMS syndrome is characterized by peripheral neuropathy (PN), a clonal plasma cell disorder (PCD), organomegaly, endocrinopathy, skin changes, edema, sclerotic bone lesions, and thrombocytosis. Based on the improved response rates observed with peripheral blood stem cell transplantation (PBSCT) in patients with other PCDs, autologous PBSCT may be an attractive treatment option for this syndrome. Sixteen patients with POEMS syndrome have undergone PBSCT at Mayo. Of these patients, 15 had a severe rapidly progressive sensorimotor PN (9 were wheelchair dependent) and 14 were male. Median age was 51 years (range, 19-62 years). The median number of prior therapies was 3 (range, 0-7). From first symptoms and from diagnosis of POEMS the times to transplantation were 42 months and 5 months (ranges, 8-185 months and 2-149 months), respectively. There were 15 patients who had significantly abnormal pretransplant pulmonary function tests. There was one transplant-related death. During the peritransplant period, 5 patients required intubation for respiratory compromise, including one who required intubation during his stem cell mobilization period. Another patient required noninvasive biphasic positive airway pressure throughout his course. Of the 14 evaluable patients, all have had neurologic improvement or stabilization. Other features have improved substantially. PBSCT for POEMS syndrome is effective therapy but may also be associated with significant morbidity. (Blood. 2004;104:3400-3407)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
Child, J. A., Morgan, G. J., Davies, F. E., Owen, R. G., Bell, S. E., Hawkins, K., Brown, J., Drayson, M. T., & Selby, P. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022340 · Cited by 1,768
Cited by
Dispenzieri, A., & Fajgenbaum, D. C. (2020) · Blood · doi:10.1182/blood.2019000931 · Cited by 487
Self-citationDispenzieri, A. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.07.004 · Cited by 311
Self-citationPOEMS Syndrome: 2019 Update on diagnosis, risk‐stratification, and management
Dispenzieri, A. (2019) · American Journal of Hematology · doi:10.1002/ajh.25495 · Cited by 286
Self-citationNarrative Review: The Systemic Capillary Leak Syndrome
Druey, K. M., & Greipp, P. R. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-2-201007200-00005 · Cited by 281
Metadata
- Authors
- Dispenzieri, A., Moreno-Aspitia, A., Suarez, G. A., Lacy, M. Q., Colon-Otero, G., Tefferi, A., Litzow, M. R., Roy, V., Hogan, W. J., Kyle, R. A., & Gertz, M. A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-11-15
- Volume
- 104
- Issue
- 10
- Pages
- 3400-3407
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2159694977
- Cited by
- 206
- References
- 1
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. https://app.cochat.ai/papers/10.1182/blood-2004-05-2046
- The paper
- Dispenzieri, A., Moreno-Aspitia, A., Suarez, G. A., Lacy, M. Q., Colon-Otero, G., Tefferi, A., Litzow, M. R., Roy, V., Hogan, W. J., Kyle, R. A., & Gertz, M. A. (2004). Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. https://doi.org/10.1182/blood-2004-05-2046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.